Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.43 |
| ▸ | HPGD | P15428 | 3/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.43 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.43 |
| ▸ | PRMT5 | O14744 | 3/20 | 0.42 |
| ▸ | WDR77 | Q9BQA1 | 3/20 | 0.42 |
| ▸ | MEN1 | O00255 | 4/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.41 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | CFTR | P13569 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6643060 | 0.83 | NOTUM (0.44) | L3MBTL1ALDH1A1SMN1; SMN2ALOX12MEN1 | |
| SCHEMBL6649352 | 0.82 | HRH3 (0.47) | L3MBTL1ALDH1A1HPGDLMNAKDM4E | |
| SCHEMBL13858089 | 0.80 | KDM4E (0.38) | L3MBTL1ALDH1A1HPGDKDM4ESMN1; SMN2 | |
| SCHEMBL5016207 | 0.77 | NOTUM (0.46) | ALDH1A1HPGDLMNAKDM4ESMN1; SMN2 | |
| SCHEMBL7683268 | 0.75 | TSHR (0.51) | ALDH1A1KDM4ESMN1; SMN2HSD17B10MEN1 | |
| SCHEMBL6646694 | 0.74 | ALDH1A1 (0.40) | L3MBTL1ALDH1A1HPGDLMNAKDM4E | |
| Dimethyl Phthalate SCHEMBL27880958 | 0.74 | TSHR (0.55) | ALDH1A1HPGDLMNAKDM4ESMN1; SMN2 | |
| SCHEMBL31305927 | 0.73 | TRPA1 (0.49) | L3MBTL1ALDH1A1LMNAKDM4EHSD17B10 | |
| SCHEMBL7408640 | 0.73 | TRPA1 (0.49) | L3MBTL1ALDH1A1LMNAKDM4EHSD17B10 | |
| SCHEMBL14852694 | 0.73 | HTR2C (0.50) | ALOX12MEN1KMT2AGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040133008-A1 | Amide compounds | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2004-07-08 | — | — | US | disclosed |
| WO-2004039795-A2 | AMIDE COMPOUNDS FOR THE TREATMENT OF HYPERLIPIDEMIA | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2004-05-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040133008-A1 | Amide compounds | APOB, APOL1, LDLR | L3MBTL1 1609/4885ALDH1A1 2174/4885HPGD 3946/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.